Navigation Links
Independent Naturopathic Clinic Receives Groundbreaking Research Grant: Partners with Global Pharmaceutical Company to Study Relief of Cancer Drug Side Effects
Date:11/5/2013

Seattle, WA (PRWEB) November 05, 2013

Northwest Natural Health Specialty Care Clinic (NNH) announced today it has been awarded a $560,000 research grant by Millennium: The Takeda Oncology Company to conduct a multiple clinical site investigation into the use of natural medicine to mitigate a side effect of bortezomib (Velcade®), an FDA approved, new generation targeted chemotherapy approved for the treatment of multiple myeloma and other cancers.

NNH created the research protocol for this FDA approved, double blinded, placebo-controlled trial and will direct its implementation at 5 clinical research institutions: Swedish Cancer Institute (part of Swedish Medical Center) in Seattle WA, Island Hospital in Anacortes WA, Yakima Valley Memorial Hospital (Northstar Lodge) in Yakima WA, Cancer Care Northwest in Spokane WA, and Northwest Medical Specialties in Puyallup WA.

The trial will run for 2 years and focus on mitigating a potential side effect of Velcade®, peripheral neuropathy, a numbness of the fingers and toes. This clinical investigation utilizes a combination of a natural amino acid (amino acids are the building blocks of dietary protein) and a special form of a B vitamin to limit Velcade® induced neuropathy.

“This clinical trial is consistent with Millennium: The Takeda Oncology Company’s commitment to continually improve cancer care,” said Randy Everett, Scientific Alliances & Research, Global Medical Affairs at Millennium. “By investing in this unique partnership with Northwest Natural Health Specialty Care Clinic, we will advance our ability to provide cancer patients with the very best care that science can provide.”

The principal investigators for this trial are Dan Labriola ND, director of NNH and Hakan Kaya MD, medical oncologist, hematologist and researcher at Cancer Care Northwest.

“Natural medicines have been used successfully throughout history to treat and prevent disease, relieve suffering and improve quality of life. This clinical trial will provide hard scientific data for one of the many opportunities to combine the best of both worlds, naturopathic care and conventional medicine,” said Labriola.

Swedish Medical Center is best known for quality patient care but also conducts clinical research in many specialties,” said Marcel Loh, Interim Chief Executive Officer, Swedish Medical Center. “There are currently more than 600 clinical trials in progress at Swedish. This clinical trial partnership with Northwest Natural Health Clinic is one more example of how we strive to make healthcare as effective and efficient as possible.”

About Northwest Natural Health Clinic

Northwest Natural Health Clinic (NNH) and its founder, Dr. Labriola, have provided coordinated integrative care in outpatient and in-hospital settings for more than 28 years. The clinic is an internationally recognized expert in the safe and effective incorporation of the benefits of naturopathic care to improve treatment outcomes and patient quality of life. Their groundbreaking naturopathic approach especially benefits patients receiving specialty medical care for cancer, heart disease, neurologic, women's health, gastrointestinal, immune system, elder care issues and more. NNH naturopathic physicians are specially trained, accredited and published in major scientific journals.

About Millennium: The Takeda Oncology Company

Millennium, the oncology arm of Takeda Pharmaceutical Company Limited, located in Cambridge Massachusetts, combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company. Millennium’s mission is to deliver extraordinary medicines like Velcade® for the treatment of multiple myeloma to patients throughout the world. Millennium is passionately committed to science, innovation and patient health.

Patient Safety Information

Vitamins, minerals, amino acids, herbs and other supplements can, in certain circumstances, interfere with treatments for cancer and other diseases. Patients should not self-treat with supplements outside of the controlled environment of this clinical trial without first discussing this with their physician.

For media inquiries, contact:
Laura E. Peterson
Five Spot Health Communications
For: Northwest Natural Health Clinic
6135 Seaview Avenue Northwest #300 Seattle, WA 98107
Seattle, WA 98107
Phone: 425.890.0095

Read the full story at http://www.prweb.com/releases/2013/10/prweb11281073.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
2. MyTownInsurance.com Reveals How Project CAP and Insurance Agoragate will Take Away Market Share from the Captive Insurance Carriers and give it back to the Independents
3. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
4. Helping Alzheimers patients stay independent
5. Independent Care to Open New Office with Service Area Expansion
6. Funding Meals on Wheels Keeps Seniors Independent: Study
7. Study shows COPD is not independent risk factor for lung cancer
8. Omega XL Reports New Independent Study:Omega-3s Help Heal Bedsores In Critically Ill
9. Independent Research Shows That Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Continues to Achieve Exceptional Scores in Customer Satisfaction
10. Yumi Media Encourages Vegetarianism For Heart Health As Reported In the Independent Florida Alligator
11. Liproxenol is First Diet Pill to Earn Perfect Score from Independent Review Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... Berkeley, and other leading institutions in announcing the launch of the Leadership ... the way animals are raised for food. , Founding members of the Leadership ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
Breaking Medicine Technology: